Tandem Diabetes Care Inc (TNDM)
47.30
+0.38
(+0.80%)
USD |
NASDAQ |
May 17, 16:00
47.30
0.00 (0.00%)
After-Hours: 20:00
Tandem Diabetes Care Enterprise Value: 2.935B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.935B |
| May 16, 2024 | 2.911B |
| May 15, 2024 | 2.939B |
| May 14, 2024 | 2.726B |
| May 13, 2024 | 2.717B |
| May 10, 2024 | 2.745B |
| May 09, 2024 | 2.725B |
| May 08, 2024 | 2.602B |
| May 07, 2024 | 2.722B |
| May 06, 2024 | 2.689B |
| May 03, 2024 | 2.768B |
| May 02, 2024 | 2.241B |
| May 01, 2024 | 2.218B |
| April 30, 2024 | 2.249B |
| April 29, 2024 | 2.273B |
| April 26, 2024 | 2.156B |
| April 25, 2024 | 2.176B |
| April 24, 2024 | 2.147B |
| April 23, 2024 | 2.137B |
| April 22, 2024 | 1.928B |
| April 19, 2024 | 1.844B |
| April 18, 2024 | 1.877B |
| April 17, 2024 | 1.930B |
| April 16, 2024 | 2.008B |
| April 15, 2024 | 1.937B |
| Date | Value |
|---|---|
| April 12, 2024 | 2.043B |
| April 11, 2024 | 2.066B |
| April 10, 2024 | 2.112B |
| April 09, 2024 | 2.132B |
| April 08, 2024 | 2.046B |
| April 05, 2024 | 2.053B |
| April 04, 2024 | 2.021B |
| April 03, 2024 | 2.092B |
| April 02, 2024 | 2.043B |
| April 01, 2024 | 2.065B |
| March 31, 2024 | 2.166B |
| March 28, 2024 | 2.103B |
| March 27, 2024 | 2.096B |
| March 26, 2024 | 1.992B |
| March 25, 2024 | 1.760B |
| March 22, 2024 | 1.770B |
| March 21, 2024 | 1.873B |
| March 20, 2024 | 1.912B |
| March 19, 2024 | 1.805B |
| March 18, 2024 | 1.826B |
| March 15, 2024 | 1.664B |
| March 14, 2024 | 1.624B |
| March 13, 2024 | 1.696B |
| March 12, 2024 | 1.780B |
| March 11, 2024 | 1.756B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
717.62M
Minimum
Nov 10 2023
9.420B
Maximum
Dec 28 2021
4.151B
Average
3.761B
Median
Enterprise Value Benchmarks
| Insulet Corp | 13.77B |
| Abbott Laboratories | 189.25B |
| Stryker Corp | 137.95B |
| Twist Bioscience Corp | 2.444B |
| Perspective Therapeutics Inc | 817.27M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -42.72M |
| Revenue (Quarterly) | 191.67M |
| Total Expenses (Quarterly) | 233.35M |
| EPS Diluted (Quarterly) | -0.65 |
| Gross Profit Margin (Quarterly) | 49.39% |
| Profit Margin (Quarterly) | -22.29% |
| Earnings Yield | -4.59% |
| Normalized Earnings Yield | -4.563 |